Teva Pharmaceuticals – Patient & Independent Medical Education Grants (2026)

2 Min Read

Supporting Education in Huntington’s Disease, Tardive Dyskinesia, and Schizophrenia

Teva Pharmaceuticals offers Patient Education and Independent Medical Education (IME) Grant Opportunitiesto support high-quality, evidence-based educational initiatives that improve understanding, care, and outcomes for people living with complex neurological and psychiatric conditions.

Organization

Teva Pharmaceuticals

Grant Name

Patient Education & Independent Medical Education Grants (2026)

Support Type

Patient Education Grants
Independent Medical Education (IME) Grants

Therapeutic Areas (2026)

Huntington’s Disease
Tardive Dyskinesia
Schizophrenia

Geographic Focus

United States

About the Funder

Teva is committed to advancing patient care through education that is scientifically rigorous, clinically relevant, and free from commercial bias. Through its grants program, Teva supports initiatives that help healthcare professionals, patients, and caregivers better understand disease progression, treatment options, and strategies to improve health outcomes.

Education Objectives – Huntington’s Disease

Priority Audience

Patients and Caregivers

Key Educational Objectives

Teva seeks to support education that:

Improves understanding of HD signs, symptoms, and disease progression
Emphasizes the importance of early diagnosis and effective disease management
Increases awareness of the impact of chorea and the importance of treatment adherence
Enhances understanding of available treatment options and advances in Huntington’s Disease research

Types of Requests Considered

✅ Eligible Grant Requests

Teva will consider Independent Medical Education (IME) and Patient Education initiatives that:

Are evidence-based and clinically relevant
Improve patient knowledge, behaviors, or health status
Support education delivered by healthcare professionals or qualified organizations
Include all required documentation
Are multi-supported when possible (preferred)

Examples of eligible patient education formats include:

Web-based education and digital applications
Educational brochures and publications
Live educational meetings and workshops

🚫 Ineligible Requests

Teva will not support:

Purchase of equipment
Salary or operational support for healthcare provider employees
General operating support
Programs where education is secondary to entertainment
Grants awarded to individuals (including individual healthcare professionals)
Programs providing compensation or expense reimbursement to non-faculty attendees

Eligible Organizations

Qualified organizations include those that provide educational opportunities for:

Physicians and healthcare professionals
Patients and caregivers

Eligible providers may include:

Community hospitals
Academic institutions
Professional societies and associations
Independent medical education companies
Nonprofit organizations
Patient advocacy groups and foundations

Applicants are responsible for content quality, scientific integrity, and any required Open Payments reporting.

Timing & Submission Guidelines

⏳ Recommended Lead Time: Submit requests at least 60 days before a funding decision is needed
⚠️ Requests received fewer than 60 days before the activity start date may not be considered

Application / Learn More

➡️ Apply via Teva’s Request Management System:
https://www.tevagrants.com/patient-grants

📧 Medical Education Team: TevaRequestManagement@tevapharm.com
📞 Phone: 1-800-961-3604 (return call within 3 business days)

Why This Opportunity Is a Good Fit

This opportunity is well suited for organizations that:

Provide patient or caregiver education in Huntington’s Disease, Tardive Dyskinesia, or Schizophrenia
Develop evidence-based, non-promotional educational content
Serve neurology or mental health patient communities
Can demonstrate clear educational outcomes and impact

Teva’s Patient and IME Grants are particularly strong for patient advocacy groups, nonprofit educators, and medical education providers focused on improving understanding and care for complex neurological conditions.

Corporate Grants Guide Notes

Review Type: Rolling (60-day minimum lead time)
Funding Focus: Patient education and independent medical education
Therapeutic Areas: Huntington’s Disease, Tardive Dyskinesia, Schizophrenia
Best Suited For: Nonprofits, advocacy organizations, and accredited education providers